The AACR Anna D. Barker Basic Cancer Research Fellowship encourages and supports postdoctoral or clinical research fellows to establish a successful career path in cancer research. The research proposed for funding may be in any area of basic cancer research.
The Blavatnik National Awards for Young Scientists recognize the United States' most promising faculty-rank researchers in Life Sciences, Physical Sciences & Engineering, and Chemistry.
Projects that will be considered for Pfizer support will focus on increasing the understanding of PARP inhibitors and the future of their use in the treatment of advanced prostate cancer. Topics of interest include Mechanisms of Action of PARP inhibitors, selection of appropriate patients, biomarker testing process, analytical platforms and result interpretation to inform decision-making, and management of patients treated with PARP inhibitors.
The Michelson Prizes are scientific awards given annually to young investigators who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research across major global diseases. The 2020 Michelson Prizes will focus on advances in human immunology to accelerate the development of more effective vaccines and immunotherapies. They will be looking for high-impact and highly innovative research that has the potential to be applied across many diseases and to significantly expand our understanding of the human immune system.
Grants support the research of faculty members or post-doctoral researchers to develop, refine, evaluate, or disseminate innovative interventions designed to prevent or ameliorate major social, psy
The Anna Lalor Burdick Program seeks to empower young women through education about healthy reproduction in order to broaden and enhance their options in life.
ENTELLIGENCE is a program designed for basic science, translational and clinical research in the field of cardiopulmonary medicine. The ENTELLIGENCE program provides opportunities for individual young investigators to promote quality medical care and enhance patients' lives by supporting research (basic science, translational and clinical research) in the area of pulmonary hypertension (PH) related to expanding our knowledge of the pathways involved in pulmonary vascular pathobiology and ultimately, to improve treatment for patients with pulmonary hypertension.
The Foundation for Physical Medicine and Rehabilitation is requesting applications for its Mid-Career Investigator Research Grants program. The grant is to be used as seed money for new research projects that extend an established investigator’s work in new directions.
The AACN Impact Research Grants are funded and supported by AACN. The AACN encourage experienced clinicians and researchers to propose projects that support inquiry and systematic research that generates new knowledge. The grants are designed to ensure a vital source of clinically relevant research for creating the evidence-based resources that influence high acuity critical care nursing practice.
Lesbians, gays, bisexuals and trans (LGBT) people face many challenges in forming, defining and maintaining families. This program seeks to encourage the study of LGBT family psychology and therapy through its support of promising young investigators whose graduate research is oriented toward issues in this general area. Preference is given to advanced students who have demonstrated their commitment to this area through their dissertation research plans.
The Foundation for Physical Medicine and Rehabilitation—Milbank Foundation Physiatric Rehabilitation after SCI or TBI Grant
The Milbank Foundation Physiatric Rehabilitation after SCI or TBI Research Grant is funded by a grant from the Milbank Foundation.
The Cancer Research Institute (CRI) and Chordoma Foundation have established a research partnership to jointly fund chordoma-focused immunology grants awarded under CRI’s Clinic and Laborator
The intent of this QI RFP is to support cancer care facilities interested in identifying and reducing unwarranted variations and/or disparities in care by:
The goal of the program is to accelerate our understanding of the biological mechanisms underlying Alzheimer’s Disease and related dementias as well as innovative approaches to better diagnose, prevent or delay the progress of the disease. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically, these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research.
The Litwin IBD Pioneers initiative, formerly known as the Broad Medical Research Program at the Crohn’s & Colitis Foundation, supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data.
The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. The Foundation supports high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported.
Established in 1967, the mission of the Crohn’s & Colitis Foundation is to cure Crohn’s disease and ulcerative colitis and to improve the quality of life of children and adults affected by these diseases.
Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Please note that applicants to the NGR program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines. While prior awardees are welcome to submit new proposals following the conclusion of the previously-sponsored project, the new proposals should not be extensions of the prior project. Additionally, Postdoctoral Fellows may be listed as Co-Principal Investigator.
This global award, administered by the New York Academy of Sciences and sponsored by Takeda Pharmaceuticals, recognizes a promising Early-Career Scientist’s and an outstanding Senior Sci
The AACR-Conquer Cancer Foundation of ASCO Young Investigator Award for Translational Cancer Research provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this jointly-supported award is to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to any area of translational cancer research.